News

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.
Eli Lilly to Acquire Gene-Editing Therapy Developer Verve Therapeutics for up to $1.3 Billion, Companies Say. By Reuters | June 17, 2025. By Reuters | June 17, 2025, at 6:54 a.m. Save Comment.
Photoelectric memristors, with the advantages of low-power consumption, high scalability and high parallelism, have provided a way for broadening the application of memristors. Photoelectric ...
Meh’: how the fast food giant lost its grip on Britain Rising costs, delivery drivers and a harassment scandal are putting people off their Big Macs Gift this article free. Daniel ...
Unpacking All the Emoji Heart Meanings and How to Use Them Right Because yes, each color means something different depending on the context! By Rachel Varina and Kayla Kibbe Published: Jun 13, 2025 ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key to regulating food intake.
Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and speed of new drug approvals. Skip to Main Content.
Community gathers to honor Burleson County Sheriff Gene Hermes “There’s no doubt in my heart where Gene is today. He loved the Lord, he loved people, and he loved this county.” ...
“We estimate that over 100 rare disease gene therapy products that had reached clinical stage have been discontinued since 2023 — not because of treatment failure, but because of the risk of market ...
Nine-month-old KJ Muldoon is the first patient to successfully receive personalized CRISPR gene editing therapy. After 300 days in the hospital, baby KJ has returned home.
Baby KJ Muldoon was born with a rare genetic disorder called CPS1 deficiency and spent nearly the entire first year of his life in the hospital. Now, he’s finally home after becoming the first ...